首页|复方丹参滴丸调控非酒精性脂肪肝小鼠的药效学作用研究

复方丹参滴丸调控非酒精性脂肪肝小鼠的药效学作用研究

扫码查看
目的 研究复方丹参滴丸对非酒精性脂肪肝(NAFLD)小鼠的药效学作用,探讨其治疗非酒精性脂肪肝的可行性。方法 SPF级健康雄性C57BL/6小鼠适应性喂养一周后,随机分为正常组和高脂饮食组,正常组用普通饲料喂养,高脂饮食组用高脂饲料喂养。8周后将高脂饮食组随机分为模型组、复方丹参滴丸组(CDDP)、阳性对照阿托伐他汀组(Ator)、复方丹参滴丸+阿托伐他汀联用组(CDDP+Ator),各组按要求给予相应的药物灌胃5周,正常组和模型组给予对应体积的生理盐水。给药结束后,小鼠进行口服葡萄糖耐量试验(OGTT)、生化指标检测和肝组织病理学观察。结果 与正常组相比,模型组小鼠体质量增长快,血糖值、OGTT-曲线下面积(AUC)、甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-c)、丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)显著升高(P<0。01),高密度脂蛋白胆固醇(HDL-c)显著降低(P<0。01),肝内脂肪沉积多;与模型组相比,CDDP组小鼠体质量增长缓慢,血糖值、OGTT-AUC、TG、TC、LDL-c、ALT、AST降低(P<0。01;P<0。05),肝内脂肪沉积较少。结论 复方丹参滴丸对NAFLD小鼠具有降低体质量、血糖值、血脂,改善肝功能、糖耐量异常,减轻肝脏脂肪变性和沉积等作用,需进一步研究其治疗NAFLD的作用机制,并探讨其成为治疗NAFLD药物的可能性。
Study on the Pharmacological Effects of Compound Danshen Dripping Pills in Regulating Non-alcoholic Fatty Liver in Mice
OBJECTIVE To study the pharmacodynamic effects of compound Danshen dropping pills on nonalcoholic fatty liver(NAFLD)in mice,and explore the feasibility of its treatment on nonalcoholic fatty liver.METHODS SPF male C57BL/6 mice were fed with a standard diet for one week and then randomly divided into the normal group and high-fat diet group.The normal group was fed with a regular diet,while the high-fat diet group was fed with a high-fat diet.After 8 weeks,the high-fat diet group was further divided into the model group,compound Danshen dripping pills group(CDDP),positive control atorvastatin group(Ator),and compound Danshen dripping pills+atorvastatin combination group(CDDP+Ator).Each group was given corresponding drug by intragastric administration for 5 weeks,while the normal group and the model group were given an equivalent volume of saline.After the administration,the mice underwent oral glucose tolerance test(OGTT),biochemical index detection,and liver histopathological observation.RESULTS Compared with the Normal group,mice in the Model group showed rapid weight gain,significantly increased blood glucose levels,OGTT-area under the curve(AUC),triglycerides(TG),total cholesterol(TC),low-density lipoprotein cholesterol(LDL-c),alanine aminotransferase(ALT),aspartate aminotransferase(AST)(P<0.01),and significantly decreased high-density lipoprotein cholesterol(HDL-c)(P<0.01),along with more hepatic fat deposition.Compared with the Model group,mice in the CDDP group showed slower weight gain,decreased blood glucose levels,OGTT-AUC,TG,TC,LDL-c,ALT,and AST(P<0.01;P<0.05),and less hepatic fat deposition.CONCLUSION Compound Danshen dripping pills have the potential to reduce body weight,blood glucose levels,blood lipids,improve liver function and abnormal glucose tolerance,and alleviate hepatic steatosis and deposition in NAFLD mice.Further researchs are ineeded to explore the underlying therapeutic mechanisms of compound Danshen dripping pills on NAFLD and its possibility as a treatment for NAFLD.

compound Danshen dropping pillsnonalcoholic fatty liverlipidosesmice

黄敏怡、申坤、黄小倩、陈嘉颖、瓮宇轩

展开 >

广州医科大学附属市八医院,广东广州 510060

广州中医药大学第一附属医院,广东广州 510405

广州中医药大学,广东广州 510405

复方丹参滴丸 非酒精性脂肪肝 脂质沉积 小鼠

2024

今日药学
广东省药学会 中国药学会

今日药学

影响因子:0.413
ISSN:1674-229X
年,卷(期):2024.34(6)